EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma

Zhen Chi iD, Lihong Chen, Weizhu Yang, Ning Huang, Jingyao Huang, Fenglin Chen

Cancer Medicine · 2026-07 · 15 (7)

DOI: 10.1002/cam4.71725 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 28.06.2026. Verfasst von Zhen Chi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Klatskin Tumor, Bile Duct Neoplasms, Brachytherapy. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Joint Funds for the Innovation of Science and Technology, Fujian province, Provincial Key Clinical Specialty Construction Project for Interventional Radiology, Fujian Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aimed to evaluate the safety and effectiveness of targeted multimodal oncological therapy in patients with unresectable hilar cholangiocarcinoma (HCCA) presenting with obstructive jaundice, particularly those with the nodular‐infiltrating morphological type.

Methods

A total of 104 patients with Bismuth type III, nodular‐infiltrating HCCA were analyzed. Fifty‐two patients received percutaneous transhepatic biliary stenting (PTBS) combined with intraluminal 125 I seed strand placement, percutaneous 125 I seed implantation, and regional chemotherapy, whereas the remaining 52 patients received percutaneous transcatheter biliary drainage tube placement plus systemic chemotherapy. Overall survival (OS), progression‐free survival (PFS), and biliary patency duration were compared between groups. Univariate and multivariate Cox regression analyses were performed to identify liver function biomarkers associated with prognosis.

Results

Intraluminal brachytherapy and percutaneous 125 I seed implantation were successfully completed in all 52 patients in the multimodal treatment group. Compared with the drainage plus systemic chemotherapy group, patients receiving multimodal therapy had significantly longer median OS (22.0 vs. 10.0 months, p < 0.001), median PFS (14.1 vs. 5.9 months), and biliary patency duration (21.0 vs. 9.0 months, p < 0.001). Multivariate analysis showed that total bilirubin and albumin were independent prognostic factors for OS in patients treated with brachytherapy and regional chemotherapy. In the drainage plus systemic chemotherapy group, total bilirubin, albumin, and alkaline phosphatase were independently associated with OS. No serious complications, such as massive hemorrhage or bile leakage, were observed.

Conclusions

Targeted multimodal oncological therapy may achieve durable local disease control, prolong biliary patency, and improve survival in patients with unresectable nodular‐infiltrating HCCA accompanied by obstructive jaundice. Future studies should further consider tumor morphological characteristics and liver function biomarkers when refining treatment strategies and prognostic assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Klatskin TumorBile Duct NeoplasmsBrachytherapyHumansFemaleMaleAgedMiddle AgedCombined Modality TherapyIodine RadioisotopesDrainageRetrospective StudiesPrognosisStentsAdultTreatment OutcomeJaundice, Obstructive

Stichwörter der Autor:innen

hilar cholangiocarcinomaiodine‐125overall survivalregional chemotherapystents

Substanzen

Iodine RadioisotopesIodine-125

Autor:innen und Institutionen

  • Department of Interventional Radiology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Department of Radiology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Department of Gastroenterology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.

ORCID-Profile: Zhen Chi

Förderung

  • Joint Funds for the Innovation of Science and Technology, Fujian province
  • Provincial Key Clinical Specialty Construction Project for Interventional Radiology
  • Fujian Provincial Natural Science Foundation of China

Zitieren

APA

Chi, Z., Chen, L., Yang, W., Huang, N., Huang, J., & Chen, F. (2026). Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma. Cancer Medicine, 15(7). https://doi.org/10.1002/cam4.71725

Vancouver

Chi Z, Chen L, Yang W, Huang N, Huang J, Chen F. Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma. Cancer Medicine. 2026;15(7). doi:10.1002/cam4.71725

BibTeX
@article{Chi2026,
  author = {Chi, Zhen and Chen, Lihong and Yang, Weizhu and Huang, Ning and Huang, Jingyao and Chen, Fenglin},
  title = {Impact of Multimodal Oncological Therapy on Survival and Local Control in Unresectable Perihilar Cholangiocarcinoma},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {7},
  doi = {10.1002/cam4.71725}
}
Kostenlos starten →